RecruitingNCT06320132

BLANDISH (Brain, Loss of Function, Aneurism, Disease, Injury, Stroke, Hemorrhage)

BLANDISH (Brain, Loss of Function, Aneurism, Disease, Injury, Stroke, Hemorrhage): Design and Internal Validation of an AI System to Support and Optimize the Management of Spontaneous Intracranial Hemorrhage Patients in the NeuroICU


Sponsor

IRCCS Ospedale San Raffaele

Enrollment

2,000 participants

Start Date

Mar 13, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to train a machine learning system based on data from patients affected by spontaneous Intracranial Hemorrage. The main question it aims to answer is whether there is a correlation between actual clinical pratice, reached outcomes and favorable or unfavorable predictive factors, and anamnesis. Participants will be treated as per standard clinical practice.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients who enter the NICU for acute spontaneous intracranial hemorrhage
  • Adult patients (≥ 18 years)
  • Sex: female, male, intersex

Exclusion Criteria5

  • All patients affected by non-spontaneous ICH
  • Patients with sICH determined by brain tumor or brain metastases
  • All patients affected by chronic ICH
  • Pregnant and puerperal women
  • Refusal to participate in the protocol

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTreatment of spontaneous intracranial hemorrhage

Data collection of therapeutic approach, including radiological, medical, surgical therapies.


Locations(1)

IRCCS Ospedale San Raffaele

Milan, MI, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06320132


Related Trials